Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

21.72
Delayed Data
As of 10:58am ET
 0.00 / 0.00%
Today’s Change
13.01
Today|||52-Week Range
22.17
+15.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues246.6M276.6M402.4M568.8M
 
 
 
 
 
Cost of Goods Sold158.8M184.4M268.5M387.0M
 
 
 
 
 
Depreciation And Amortization15.9M18.4M27.0M50.6M
 
 
 
 
 
 
Operating ExpensesGross Income71.9M73.8M106.8M131.1M
 
 
 
 
 
General Expenses40.8M47.6M81.2M138.2M
 
 
 
 
 
Research And Development414.0K1.0M5.5M16.0M
 
 
 
 
 
Total Operating Expenses215.4M250.4M376.7M575.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income31.1M26.2M25.6M-7.1M
 
 
 
 
 
Extraordinary Credit0.00--600.0K1.7M
 
 
 
Extraordinary Charge-11.0M-21.7M-12.0M-19.8M
 
 
 
 
 
Interest Expense On Debt1.3M11.0M19.4M39.9M
 
 
 
 
 
Other Expenses772.0K1.1M1.6M5.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income19.7M-5.5M-3.5M-60.0M
 
 
 
 
 
Income Taxes-7.0M-2.2M-1.2M-10.2M
 
 
 
 
 
Net Income12.7M-3.3M-2.3M-70.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS30.9M31.5M33.2M38.3M
 
 
 
 
 
Shares To Calculate EPS Diluted31.8M31.5M33.2M38.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.40-$0.10-$0.07-$1.83
 
 
 
 
 
EPS Diluted$0.40-$0.10-$0.07-$1.83